Illumina to Present at Upcoming Investment Conferences in May
April 27 2010 - 6:00AM
Business Wire
Illumina, Inc. (NASDAQ:ILMN) today announced that the Company
will webcast its presentations at two upcoming investment
conferences.
Illumina will webcast its presentation at the Deutsche Bank
Securities Annual Health Care Conference in Boston, Massachusetts
on Tuesday, May 4, 2010. The live webcast is scheduled to begin at
8:00 a.m. ET and will feature a brief overview of the company by
Christian Henry, senior vice president, chief financial officer and
general manager of Life Sciences, followed by a question and answer
session. Illumina will also webcast its presentation at the Baird
Growth Stock Conference in Chicago, Illinois on Wednesday, May 19,
2010. The live webcast is scheduled to begin at 12:15 p.m. ET and
will feature an overview of the company by Christian Henry,
followed by a question and answer session.
These live webcasts can be accessed under the
"Corporate/Investor Information" tab of Illumina's web site at
www.illumina.com.
About Illumina
Illumina (http://www.illumina.com) is a leading developer,
manufacturer, and marketer of life-science tools and integrated
systems for the large-scale analysis of genetic variation and
biological function. Using our proprietary technologies, we provide
a comprehensive line of products and services that currently serve
the sequencing, genotyping, and gene expression markets, and we
expect to enter the market for molecular diagnostics. Our customers
include leading genomic research centers, pharmaceutical companies,
academic institutions, clinical research organizations, and
biotechnology companies. Our tools provide researchers around the
world with the performance, throughput, cost effectiveness, and
flexibility necessary to perform the billions of genetic tests
needed to extract valuable medical information from advances in
genomics and proteomics. We believe this information will enable
researchers to correlate genetic variation and biological function,
which will enhance drug discovery and clinical research, allow
diseases to be detected earlier, and permit better choices of drugs
for individual patients.
Forward-Looking Statements
This release may contain forward-looking statements that involve
risks and uncertainties. Important factors that could cause actual
results to differ materially from those in any forward-looking
statements are detailed in our filings with the Securities and
Exchange Commission, including our most recent filings on Forms
10-K and 10-Q, or in information disclosed in public conference
calls, the date and time of which are released beforehand. We do
not intend to update any forward-looking statements after the date
of this release.
Illumina (NASDAQ:ILMN)
Historical Stock Chart
From Aug 2024 to Sep 2024
Illumina (NASDAQ:ILMN)
Historical Stock Chart
From Sep 2023 to Sep 2024